Europe Launches 2018 with $3.3 Billion Investment in First-Quarter Pharmaceutical-Biotech Construction Starts
Europe Launches 2018 with $3.3 Billion Investment in First-Quarter Pharmaceutical-Biotech Construction Starts
Attachment: European Pharma-Biotech Kickoffs 1Q17, European 1Q17 Pharma-Biotech Kickoffs
SUGAR LAND--February 27, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The European Pharmaceutical & Biotech Industry, better described as the Life Science Industry, includes the development and production of pharmaceuticals, biologicals, medical devices and cosmetics. Europe's volume of project activity continues to impress, all the more so, when the reported activity is expanded to include Russia and Turkey in Western Asia.
Within this article: Details of the European Pharma-Biotech Industry
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Germany's Lower Saxony a Hotspot for Green Hydrogen
- Idaho Sees More than $1 Billion of Projects Under Construction
- U.S. Chemical Projects Worth $18 Billion to Reach Finish Line This Year
- Shell Starts Operations at Pennsylvania Polyethylene Complex
- Shell's Pennsylvania Ethylene Unit Gears Up for Startup